Preeclamptic women are deficient of interleukin-10 as assessed by cytokine release of trophoblast cells in vitro

Cytokine

Volumn 23, Issue 4-5, 2003, Pages 119-125

  Rein, D T ^a,e   Breidenbach, M ^b   Honscheid B ^b   Friebe Hoffmann, U ^a   Engel, H ^c   Gohring U J ^d   Uekermann, L ^b   Kurbacher, C M ^b   Schondorf T ^b  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b UNIVERSITY OF COLOGNE   (Germany)

^c HANNOVER MEDICAL SCHOOL   (Germany)

^d Johanniter Krankenhaus   (Germany)

^e University of Alabama at Birmingham   (United States)

Author keywords

Cytokine release; IL 10; In vitro; Preeclampsia; Trophoblast culture

Indexed keywords

CYTOKINE; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 2; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CELL ISOLATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IMMUNE RESPONSE; IMMUNOREGULATION; IN VITRO STUDY; PLACENTA; PREECLAMPSIA; PREGNANCY; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SYNTHESIS; QUANTITATIVE ANALYSIS; THIRD TRIMESTER PREGNANCY; TISSUE CULTURE; TROPHOBLAST;

EID: 0042837971     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1043-4666(03)00220-5     Document Type: Article

References (44)

1. National High Blood Pressure Education Program Working Group. Report on high blood pressure in pregnancy. Am J Obstet Gynecol. 163:1990;1689-1712.
2. Khong T.Y., Robertson W.B. Spiral artery disease. Coulam C.B., Faulk W.P., McIntyre J.A. Immunological obstetrics. 1992;492-501 Norton, New York.
3. Roberts J.M., Tylor R.N., Musci T.J., Rodgers G.M., Hubel C.A., McLaughlin M.K. Preeclampsia: an endothelial cell disorder. Am J Obstet Gynecol. 161:1989;1200-1204.
4. Pober J.S., Cotran R.S. Cytokines and endothelial cell biology. Physiol Rev. 70:1990;427-451.
5. Kameda T., Matsuzaki N., Sawai K., Okada T., Saji F., Matsuda T., et al. Production of interleukin-6 by normal human trophoblast. Placenta. 11:1990;205-213.
6. Chen H.L., Yang Y.P., Hu X.L., Yelavarthi K.K., Fishback J.L., Hunt J.S. Tumor necrosis factor alpha mRNA and protein are present in human placental and uterine cells at early and late stages of gestation. Am J Pathol. 139:1991;327-335.
7. Hu X.-L., Yang Y., Hunt J.S. Differential distribution of interleukin-1α and interleukin-1β proteins in human placentas. J Reprod Immunol. 22:1992;257-268.
8. Benyo D.F., Miles T.M., Conrad K.P. Hypoxia stimulates cytokine production by villous explants from the human placenta. J Clin Endocrinol Metab. 82:1997;1582-1588.
9. Anderson J.A., Miller F.N., Sims D.E., Edwards M.J. Tumor necrosis factor causes microvascular protein leakage independently of neutrophils or mast cells. J Surg Res. 56:1994;485-490.
10. Hotamisligil G.S., Spiegelman B.M. Tumor necrosis factor alpha: a key component of the obesity-diabetes link. Diabetes. 43:1994;1271-1278.
11. Darmochwal-Kolarz D., Leszczynska-Gorzelak B., Rolinski J., Oleszczuk J. T helper 1- and T helper 2-type cytokine imbalance in pregnant women with pre-eclampsia. Eur J Obstet Gynecol Reprod Biol. 86:1999;165-170.
12. Rein D.T., Schöndorf T., Göhring U.J., Kurbacher C.M., Pinto I., Breidenbach M., et al. Cytokine expression in peripheral blood lymphocytes indicates a Switch to T helper cells in patients with preeclampsia. J Reprod Immunol. 54:2002;133-142.
13. Conrad K.P., Miles T.M., Benyo D.F. Circulating levels of immunoreactive cytokines in women with preeclampsia. Am J Reprod Immunol. 40:1998;102-111.
14. Conrad K.P., Benyo D.F. Placental cytokines and the pathogenesis of preeclampsia. Am J Reprod Immunol. 37:1997;240-249.
15. Tangri S., Wegmann T.G., Lin H., Raghupathy R. Maternal antiplacental reactivity in natural, immunologically-mediated fetal resorptions. J Immunol. 154:1994;4903-4911.
16. Chaouat G., Assal-Meliani A., Martal J., Raghupathy R., Elliot J., Mosmann T., et al. IL-10 prevents naturally occurring fetal loss in the CBA X DBA/2 mating combination, and local defect in IL-10 production in this abortion-prone combination is corrected by in vivo injection of IFN-γ J Immunol. 154:1995;4261-4268.
17. de Wall M.R., Abrams J., Bennett B., Figdor C., de Vries J.E. Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: an immunoregulatory role of IL-10 produced by monocytes. J Exp Med. 174:1991;1209-1220.
18. Fiorentino D.F., Zlotni K.A., Vieira P., Mosman T.R., Howard M., Moore K.W., et al. IL-10 acts on the antigen presenting cell to inhibit cytokine production by Th1 cells. J Immunol. 146:1991;3444-3451.
19. Choi B.C., Polgar K., Xiao L., Hill J.A. Progesterone inhibits in-vitro embryotoxic Th1 cytokine production to trophoblast in women with recurrent pregnancy loss. Hum Reprod. 15:(Suppl 1):2000;46-59.
20. Rivera D.L., Olister S.M., Liu X., Thompson H., Zhang X.J., Pennline K., et al. Interleukin-10 attenuates experimental growth restriction and demise. FASEB J. 12:1998;189-197.
21. 1, and epithelial cadherin in preeclampsia. Obstet Gynecol. 100:2002;327-331.
22. Rinehart B.K., Terrone D.A., Lagoo-Deendayalan S., Barber W.H., Hale E.A., Martin J.N., et al. Expression of the placental cytokines tumor necrosis factor α, interleukin 1β, and interleukin 10 is increased in preeclampsia. Am J Obstet Gynecol. 181:1999;915-920.
23. Hennessy A., Pilmore H.L., Simmons L.A., Painter D.M. A deficiency of placental IL-10 in preeclampsia. J Immunol. 163:1999;3491-3495.
24. Kliman H.J., Nestler J.E., Semasi E., Sanger J.M., Strauss J.F. Purification, characterization and in-vitro differentiation of cytotrophoblasts from human term placenta. Endocrinology. 118:1986;1567-1582.
25. Frank H.G., Genbacev O., Blaschitz A., Chen C.P., Clarson L., Evain-Brion D., et al. Cell culture models of human trophoblast-primary culture of trophoblast - a workshop report. Placenta. 21:(Suppl A):2000;106-112.
26. Bennet W.A., Lagoo-Deendayalan S., Bracklin M.N., Hale E., Cowan B.D. Cytokine expression by models of human trophoblast as assessed by a semiquantitative reverse transcription-polymerase chain reaction technique. Am J Reprod Immunol. 36:1996;285-294.
27. Huppertz B., Frank H.G., Reister F., Kingdom J., Korr H., Kaufmann P. Apoptosis cascade progresses during turnover of human trophoblast: analysis of villous cytotrophoblast and syncytial fragments in vitro. Lab Invest. 79:1999;1687-1702.
28. Osman F., Jarrous N., Ben-Asouli Y., Kaempfer R. A cis-acting element in the 3′-untranslated region of human TNF-alpha mRNA renders splicing dependent on the activation of human protein kinase PKR. Genes Dev. 13:1999;3280-3293.
29. Gul T.G., Posaci C., Caliskan S. The role of enalapril in the prevention of ovarian hyperstimulation syndrome: a rabbit model. Hum Reprod. 16:2001;2253-2257.
30. Bennet W.A., Lagoo-Deendayalan S., Withworth N.S., Stopple J.A., Barber W.H., Hale E., et al. First trimester chorionic villi express both immunoregulatory and inflammatory cytokines: a role for interleukin-10 in regulating the cytokine network of pregnancy. Am J Reprod Immunol. 41:1999;70-76.
31. Roth I., Corry D.B., Locksley R.M., Abrams J.S., Litton M.J., Fisher S.J. Human placental cytotrophoblasts produce the immunosupressive cytokine interleukin 10. J Exp Med. 184:1996;539-548.
32. Wegmann T.G., Lin H., Guilbert L., Mosmann T.R. Bidirectional cytokine interactions in the maternal-fetal relationship: is successful pregnancy a Th2 phenomenon? Immunol Today. 14:1993;353-357.
33. Piccinni M.P., Scaletti C., Maggi E., Romagnani S. Role of hormone-controlled Th1- and Th2-type cytokines in successful pregnancy. J Neuroimmunol. 109:2000;30-33.
34. Saito S., Umekage H., Sakamoto Y., Sakai M., Tanebe K., Sasaki Y. Increased T-helper-1-type immunity and decreased T-helper-2-type immunity in patients with preeclampsia. Am J Reprod Immunol. 41:1999;297-306.
35. Wang Y., Walsh S.W. TNF-α concentrations and mRNA expression are increased in preeclamptic placentas. J Reprod Immunol. 32:1996;157-169.
36. Chen G., Wilson R., Wang S.H., Zheng H.Z., Walker J.J., McKillop J.H. Tumor necrosis factor-alpha (TNF-α) gene polymorphism and expression in preeclampsia. Clin Exp Immunol. 104:1996;154-159.
37. Benyo D.F., Smarason A., Redman C.W., Sims C., Conrad K.P. Expression of inflammatory cytokines in placentas from women with preeclampsia. J Clin Endocrinol Metab. 86:2001;2505-2518.
38. Sunder Plasmann G., Derfler K., Wagner L., Stockenhuber F., Endler M., Nowotny C., et al. Increased serum activity of interleukin-2 in patients with preeclampsia. J Autoimmun. 2:1989;203-205.
39. Sacks G.P., Studena K., Sargent I.L., Redman C.G.W. Normal pregnancy and preeclampsia both produce inflammatory changes in peripheral blood leukocytes akin to those of sepsis. Am J Obstet Gynecol. 179:1998;80-86.
40. Kupferminc M.J., Peaceman A.M., Aderka D., Wallach D., Socol M.L. Soluble tumor necrosis factor receptors and interleukin-6 levels in patients with severe preeclampsia. Obstet Gynecol. 88:1996;420-427.
41. Kauma S.W., Wang Y., Walsh S.W. Preeclampsia is associated with decreased placental interleukin-6 production. J Soc Gynecol Invest. 2:1995;614-617.
42. Opsjon S.L., Austgulen R., Waage A. Interleukin-1, interleukin-6 and tumor necrosis factor at delivery in preeclamptic disorders. Acta Obstet Gynecol Scand. 74:1995;19-26.
43. Hirano T., Higuchi T., Ueda M., Inoue T., Kataoka N., Maeda M., Fujiwara H., Fujii S. CD9 is expressed in extravillous trophoblast in association with integrin alpha3 and integrin alpha5. Mol Hum Reprod. 5:1999;162-167.
44. Blaschitz A., Weiss U., Dohr G., Desoye G. Antibody reaction patterns in first trimester placenta: Implications for trophoblast isolation and purity screening. Placenta. 21:2000;733-741.